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ABSTRACT
Objective: To analyze the effectiveness of 2% and 4% papain gels in tissue repair of 
venous ulcers. Method: Quasi-experimental study with consecutive sample of 16 
patients with 30 venous ulcers treated at the outpatient clinic of a teaching hospital, 
from April to November in 2011, using a form for clinical assessment of the patient and 
its lesion. Variables were analyzed by Wilcoxon and McNemar test (p < 0.05). Results: 
Most participants were female; aged between 51 and 59 years; obese; with hypertension. 
Regarding ulcers, there was an average decrease of 7.9 cm2 (50% of its original size) in 
90 days; 20% of the ulcers completely healed within 56.67 days. There was an increase 
in epithelialization, significant reduction in the slough and edema, improved depth, in 
the type and amount of exudate (p < 0.0001). Conclusion: 2% and 4% papain gels were 
effective in healing venous ulcers.
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INTRODUCTION
Venous ulcers are considered a worldwide public health 
problem due to its high incidence, high cost of treatment 
and its impact on patient quality of life in physical, emo-
tional and social spheres, and may lead to loss of work ca-
pacity and increase early retirement(1-2). The understanding 
of care for venous ulcers is important for decision making 
and multidisciplinary intervention and represents a starting 
point for appropriate public health policies(3).
There are several types of coverage and products used for 
performing ulcer dressing, including papain, which comes 
from the latex green papaya fruit (Carica papaya), common-
ly found in Brazil. It is a complex mixture of proteolytic 
enzymes and peroxidase, which causes proteolysis of the de-
vitalized tissue. It is a chemical debriding agent introduced 
in Brazil in 1983, used in various wounds etiologies, at all 
stages of the healing process and in patients of different age 
groups, showing positive results(4).
In order to enhance the knowledge of its properties, 
studies with papain as a technology has been advancing. 
One of these properties is the ability to reduce biofilm on 
surfaces of medical devices formed by methicillin-resistant 
Staphylococcus epidermidis (MRSE) bacteria, and meth-
icillin-resistant Staphylococcus haemolyticus (MRSHa) 
frequently isolated from the human bacteremia(5).
However, a major challenge to the use of papain is to 
maintain the stability of its enzymatic action. Most en-
zymes are not stable at room temperature and lose their 
biological activity in a short period of time. Its association 
with other substances is difficult and requires the attention 
of nurses because papain is inactivated when reacting with 
oxidizing agents such as iron, oxygen, iodine derivatives, 
hydrogen peroxide and silver nitrate, light and heat. The 
papain solution prepared with distilled water or saline solu-
tion also showed poor durability(4).
Therefore, researchers and professors from the School 
of Nursing and the School of Pharmacy from the Universi-
dade Federal Fluminense, developed and tested the papain 
gels in the concentrations of 2% and 4%, using Carbomer 
940 vehicle technology to maintain stability of the enzyme. 
Carbomers 940 are synthetic high molecular weight poly-
mers formed by repeating acrylic acid units, bioadhesive 
materials used as gelling agents and stabilizers of emul-
sions(6). The use of papain gels have become a trend in Bra-
zil, due to its ability to maintain the enzymatic stability of 
papain in a more satisfying way than in diluted powder(4).
Another important aspect regarding the use of papain 
is that although it has been established for decades, there is 
no consensus among nurses in relation to the concentration, 
method used, the duration of the solution after dilution and 
the indications for the use of papain(7), demonstrating the 
need for more research to contribute with evidence of the 
effect of papain, promoting the basis for decision making 
regarding its use in venous ulcers.
In addition, the care of venous ulcers requires constant 
updating, thus, the preparation and application of clinical 
protocols that promote the improvement of care for ve-
nous ulcers and ongoing training of health professionals are 
extremely important(8) and may be used as a foundation for 
further research on the subject.
Therefore, this study aimed to analyze the effectiveness 
of 2% and 4% papain gels in tissue repair of venous ulcers.
METHOD
This is a quasi-experimental study in which the venous 
ulcers were treated with 2% and 4% papain gels and evalu-
ated before and after exposure to the intervention, through 
a research protocol on which the bed ulcers only received 
treatment with papain gels in the cited concentrations.
The study met the ethical principles of Resolution No. 
196/96 of the Brazilian National Health Council and was 
approved by the Research Ethics Committee of the School 
of Medicine of the Universidade Federal Fluminense, with 
the No. 196/08 and CAAE No 0154.0.258.000-08(9). Pa-
tients expressed their willingness to participate in the study 
by signing the Consent Form.
The study was conducted in two stages: the first stage 
delimited the production of papain gels formulations, by 
professors and pharmaceutical professionals of the Uni-
versity School of Pharmacy, seeking stability and product 
quality. Sensory evaluation were carried out by specialist 
nurses and the production process mapped by international 
standards of quality control to ensure the perfect reproduc-
ibility of the product.
The second stage was developed at a Wound Healing 
Clinic of a public Teaching Hospital, quaternary level, refer-
ence for the treatment of chronic lesions of Niteroi city and 
surrounding areas.
A consecutive sample was composed of patients seen 
in the clinic from April to November in 2011, who met 
the following inclusion criteria: age over 18 years; who 
presented venous ulcer dimensions greater than 2.0 cm2; 
who was clinically referred to the use of papain gels in 
concentrations of 2% and 4%, or presented the ulcer bed 
granulation tissue or the liquefaction necrosis or slough 
to 100%; who demonstrated understanding of the health 
team’s guidance or who had a legal guardian to ensure con-
tinuity of care at home.
Exclusion criteria were: allergy to the product of the 
research; any type of allergy to latex; circular lesions on the 
lower limbs; psychiatric diseases; pregnancy and lactation; 
arterial ulcers; infection at the site of lesion and lack of con-
tinuity of home treatment. Circular lesions were excluded 
due to difficulty of planimetry evaluation to monitor the 
evolution of injury. The exclusion of pregnant and lactating 
women occurred because there were no voluntareer with 
these characteristics in this clinical study. Volunteers with 
infection at the lesion site were excluded by the need to use 
medication and therapy not included in the study, such as 
systemic or local antibiotics.
After orientation and signature of the Consent Form by 
the participants, 21 volunteers were included with 39 ulcers. 
Five were excluded for reasons such as: disorientation and 
lack of a guardian; tendons’ exposure and pain complaints, 
whereas the gold standard treatment for this condition is 
graft tissue and there is no evidence of the use of papain 
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on the tendon; erysipelas infection, due to the need for 
systemic antibiotics; death caused by Acute Renal Failure. 
A total of 16 patients remained with 30 ulcers, with follow-
up time of 90 days, for a total of 191 consultations, with an 
average of 12 visits per patient (SD = ± 1.75).
For data collection, instruments and service protocols 
were used, containing sociodemographic and clinical data of 
the patient and lesion. To determine the underlying disease, 
we used the records of medical diagnosis from charts.
Each subject was evaluated once a week and the mea-
surement of the lesions was performed through an adhe-
sive technique and photographic record every 15 days. The 
measurement was carried out after cleaning the wound with 
0.9% saline solution in the case of granulation tissue, and 
neutral soap in perilesional region in cases of slough and 
abundant exudate, according to protocol. The photographic 
record was made with a digital Camera with 90° focus of 
the lesion, and a distance of 50 cm.
The following concentrations of papain were used: at 
home, 2% papain gel wt/wt (percentage weight-weight) 
once a day or every dressing changes required in the case of 
excess exudate regardless of the amount of slough . In the 
clinic, 4% papain gel (wt/wt) once a week, when the amount 
of slough in the wound bed was higher than 50% of the 
tissue in the wound bed and 2% papain gel (wt/wt) where 
the amount of slough in the wound bed was less than 50%. 
4% papain is the highest concentration of the study, so it 
was applied under professional supervision in the clinic, to 
control adverse reactions(4).
As clinic protocol, at the perilesional region, we advised 
patients to use lubricants and moisturizers for skin such as 
creams or oils containing essential fatty acids (EFA); urea 
cream; liquid vaseline or mineral oil. Care should not be re-
stricted only to the ulcer, but also the perilesional region(10). 
EFA are widely used in Brazil without contraindications or 
side effects(11).
The dressings were performed once a week in the clinic 
by the researcher and changed daily at home by the patient, 
previously advised and trained. For daily exchange, we pro-
vided a dressing kit weekly to each patient with the follow-
ing materials: tube of 2% papain gel, gauze, bandages and 
tape to the dressing fixation. For the transport of papain gel, 
we provided a freezer bag and a reusable artificial ice sheet.
We also provided them a leaflet containing hours of 
attendance, telephone contact in case of any problem or 
doubt, with information about the transport and storage of 
the product (keep the tube of gel in a clean plastic bag, in-
side the refrigerator, on the second shelf; it should always be 
transported in a box or freezer bag with ice); care in chang-
ing the dressing at home every 24 hours or when the ban-
dage presented signs of saturation, exudate accumulation; 
extra care not to wet the dressing while taking a shower; 
application of the product only within the wound and do 
not use metal objects to spread the product on the gauze.
In addition, the patient or her/his legal guardian was 
advised about the importance of maintaining the product 
refrigerated, with removal of the tube from the refrigerator 
only at the moment of dressing in order to maintain enzy-
matic stability and product use conditions, given that pa-
pain is thermolabile and loses its enzymatic activity when 
exposed to heat(4).
Research data were collected by the researchers them-
selves after training. The analysis variables of primary 
outcomes were: evolution of the area of venous ulcers; per-
centage of healed ulcers and the evolution of the type of 
tissue in the bed of the lesions. For the secondary outcomes 
were considered: depth; type and amount of exudate of the 
lesion; odor; pain; perilesional edema; adverse reactions 
such as itching and pain after using the product; and char-
acteristics of edges and the adjacent skin.
The inferential analysis consisted of the following meth-
ods: the variation of the area of early injury to the end of 
treatment was analyzed using the Wilcoxon test; the com-
parison of the absolute delta (cm2) and relative (%) of the 
lesion area was analyzed by Kruskal-Wallis ANOVA and 
by multiple comparison of the Dunn test; the variation of 
tissue in the wound bed and lesion characteristics (ordinal 
variables) from baseline to end of treatment were measured 
by McNemar test.
Nonparametric methods were used because the ar-
eas of values were not normally distributed (Gauss-
ian distribution), due to the wide dispersion of data 
and rejection of the hypothesis of normality according 
to the Kolmogorov-Smirnov test. The significance 
level adopted was 5%. Statistical analysis was per-
formed with the statistical software SAS® System ver-
sion 6.11 (SAS Institute, Inc., Cary, North Carolina).
RESULTS
Most participants were female (56.25%), a ratio of 1.2:1; 
aged between 51 and 59 years (56.25%), and low educa-
tional level (62.50%). The average age of the volunteers was 
62.31 years, median of 58.50 years and standard deviation 
of ± 10.15. Only 6.25% were smokers and 12.50% reported 
occasional use of alcohol.
The Body Mass Index (BMI) shows that 87.50% of the 
volunteers were considered outside the normal weight stan-
dards: 6.25% underweight; 6.25% overweight; 43.75% with 
obesity class I; 18.75% with obesity class II and 12.50% 
with obesity class III.
Regarding underlying diseases, 37.50% of the volun-
teers had systemic arterial hypertension (SAH) and 25% of 
Chronic Venous Insufficiency (CVI); 37.50% had, in addi-
tion to hypertension, other diseases, 18.75% with Diabetes 
Mellitus; 12.5% with Chronic Venous Insufficiency and 
6.25% with both conditions.
CharaCteristiCs of venous ulCers
The majority, 62.5% of the volunteers, had more than 
one lesion and 12.5% reported reincidence after other treat-
ments. Regarding occurance time, 43.75% had venous ul-
cers for less than three years and 12.5% for over ten years. 
The average time was five years, with a median of 4 years 
and a standard deviation of ± 6 years. The minimum time 
was five months and a maximum of 25 years. According 
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to the Spearman coefficient, there was no significant cor-
relation between age and the time of lesion (r = -0.088; p = 
0.74) in the 16 study volunteers.
Regarding the site of ulcers, 50% were in the malleolus 
region, 40% in thirds of the leg (upper, middle and lower) 
and 10% in the foot dorsum. As for the primary outcome, 
evolution of the area of venous ulcers, 93.33% had a re-
duction of which 20% reduced completely. Only 6.67% in-
creased from 16 to 29% of their areas.
Considering the whole sample, there was a significant 
reduction in the area 7.9 cm2 on average (p = 0.0001), cor-
responding to an average of 50% (p = 0.0001) in the area of 
ulcers after 90 days of treatment. Due to the large variability 
observed in the initial lesion area (2 to 120 cm2) in this sam-
ple, the impact of treatment was also examined separately 
in three subgroups of initial area: between 2 cm2 to 3,9 cm2 
(n = 10); from 3,9 to 20 cm2 (n = 10) and > 20 cm2 (n = 10).
In the subgroup with inicial area of 2 cm2 to 3.9 cm2 
there was a significant reduction in average of 1.6 cm2 (p = 
0.005), which corresponds to 60% (p = 0.003) in the area 
of those ulcers. There was complete healing of four venous 
ulcers in this subgroup.
In the subgroup with inicial area between 3.9 to 20 cm2 
there was a significant reduction in average of 6.5 cm2 (p = 
0.005), which corresponds to 66.6% (p = 0.005) in the area 
of those ulcers. Two ulcers were completely healed in this 
subgroup.
In the subgroup with inicial area of > 20 cm2, there was 
a significant reduction in lesion area, on average, 15.7 cm2 
(p = 0.002), which corresponds to 23.7% (p = 0.002). There 
was no significant difference at the level of 5%, in the heal-
ing of the subgroups < 3.9 cm2 and 3.9 to 20 cm2.
The percentage of healed ulcers was 20%, all inicial areas 
were less than or equal to 4 cm2, 66.6% had occurred over 
twelve months before the study (SD = ± 22 months). The 
age of patients whose wounds were healed varied between 
51 and 72 years, with an average of 60.25 and a median of 
59 years, with a standard deviation of ± 9.98. The average 
healing time was 56.67 days, with a median of 60 days, 
standard deviation of ± 9.83.
Regarding the evolution of tissue in the bed of venous 
ulcers, the types of tissues that could be found in the bed 
of the ulcers were divided into four groups: necrotic tissue, 
slough, granulation tissue and epithelialization. No ulcer 
had dried necrosis. The variation in bed tissue of the ulcers 
after treatment with the papain gel was evaluated accord-
ing to its intensity, semi-quantitatively varying in six levels: 
0%; 1-25%; 26-50%; 51-75%; 76-99% and 100%, which 
represent the amount estimated in the visual assessment of 
the wound, in each nursing visit (Table 1).
In the total sample, as shown in Table 1, there was sig-
nificant reduction of slough in the tissue (p < 0.001) and 
a significant increase in epithelialization (p < 0.001) from 
baseline to end of treatment. There were no significant 
changes in granulation tissue (p = 0.25). The use of papain 
gel demonstrated their activity as debriding slough in the 
tissue, providing a significant reduction in the quantity of 
this tissue.
Table 1 – Intensity of the tissues at the baseline and at the end of 
treatment – Niteroi, RJ, Brazil, 2011.




days) p value a
n % n %
Slough
0% 0 0 10 33.3
< 0.001
1-25% 12 40.0 17 56.7
26-50% 9 30.0 3 10.0
51-75% 2 6.7 0 0
76-99% 7 23.3 0 0
100% 0 0 0 0
granulation
0% 2 6.7 7 23.3
0.25
1-25% 7 23.3 2 6.7
26-50% 8 26.7 4 13.3
51-75% 5 16.7 9 30.0
76-99% 8 26.7 8 26.7
100% 0 0 0 0
Epithelialization
0% 4 13.3 0 0
< 0.001
1-25% 26 86.7 14 46.7
26-50% 0 0 7 23.3
51-75% 0 0 2 6.7
76-99% 0 0 1 3.3
100% 0 0 6 20.0
a = McNemar test.
Table 2 - Lesion characteristics at baseline and end of 





(90 days) p valuea
n % n %
Depth
Healed - - 6 20.0
0.001Superficial 8 26.7 14 46.7
Partial 22 73.3 10 33.3
Exudate type
None - - 6 20.0
0.0001
Serous 3 10.0 13 43.3
Serosangui-
neous 25 83.3 11 36.7
Purulent 2 6.7 0 0.0
Exudate 
amounts
None - - 6 20.0
< 0.0001
Small 9 30.0 13 43.3
Medium 15 50.0 11 36.7
Large 6 20.0 0 0.0
Foul odor
Yes 1 3.3 0 0.0
0.99
No 29 96.7 30 100.0
Pain in the 
bed of venous 
ulcers
Yes 13 43.3 8 26.7
0.30




Yes 2 6.7 6 20.0
0.28
No 28 93.3 24 80.0
Perilesional 
edema
Yes 25 83.3 6 20.0
< 0.0001
No 5 16.7 24 80.0
Ulcer edges
Epithelized 27 90.0 28 93.3
0.99
Macerated 3 10.0 2 6.7
Adjacent skin
Hydrated 19 63.3 26 86.7 0.096
Dried 11 36.7 4 13.3
a = McNemar test.
Table 2 shows the variables of the secondary outcomes 
regarding the characteristics of venous ulcers.
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As shown in Table 2, a significant improvement after 
treatment with the papain gel, the depth (p = 0.001), the 
type and amount of exudate ulcers (p = 0.0001) and edema 
(p < 0, 0001). There were no significant differences in other 
characteristics of the ulcers as odor, pain, pain after using 
the product, edges and adjacent skin to the lesion. It was 
considered as superficial depth of ulcer one that affects the 
epidermis and dermis, and partial when it affects the sub-
cutaneous tissue(12). None of the participants had adverse 
reactions to the product.
DISCUSSION
Regarding sociodemographic characteristics, most par-
ticipants of the study were female. Statistics show both na-
tionally and internationally that venous ulcers have a higher 
prevalence in female population, due to pregnancy and the 
presence of hormones that predispose the occurrence of 
Chronic Venous Insufficiency and venous ulcers(13-15) How-
ever, some studies have presented a higher incidence in 
males(1,16).
Most participants observed age in this study was pa-
tients between 51 and 59 years. Although the prevalence 
of venous ulcers is greater in the elderly(13,15), the early oc-
currence of the ulcer is related to the higher prevalence of 
comorbidities, the increased risk of complications and poor 
prognosis(1,16).
Most of the study participants did not smoke or con-
sumed alcohol on a daily basis. This is a positive factor be-
cause smoking is considered a risk factor for venous ulcer 
and unfavorably interferes with the tissue healing process, 
because it interferes in tissue oxygenation, oxidative stress 
which affect the function of macrophages and change in the 
levels of vitamin C and collagen(17-18).
Regarding the Body Mass Index (BMI), most partici-
pants had some degree of obesity and had one or more dis-
eases such as systemic hypertension, the Chronic Venous 
Insufficiency and Diabetes Mellitus. Both obesity and the 
presented underlying diseases are risk factors for the devel-
opment of venous ulcers and delayed healing(19).
The venous ulcer is the most serious consequence of 
chronic venous insufficiency, they are considered a long-
term problem and of frequent recurrence, 30% in the first 
year, rising to 78% after two years(13,16).
The malleolus region was the most affect regarding the 
location of the studied ulcers. The location varies among 
studies, with higher occurrence in malleolar region(17); lower 
third or distal half(1,14).
Lesion characteristics directly influence the quality of 
life of patients with venous ulcers(15). The primary outcome 
observed in this study, evolution of the area of venous ulcers, 
pointed out that the total sample was significantly reduced 
and ulcers that were between 3.9 cm2 to 20 cm2 were the most 
benefited from the use of papain gel, and smaller than 3.9 
cm2 also demonstrated an excellent average reduction. More 
than half of study ulcers were reduced by at least 60% of their 
areas, showing a favorable rate of reduction to the use of pa-
pain gel. Ulcers with an area greater than 24 cm2 are consid-
ered poor prognosis due to the poor conditions for healing(16).
The percentage of healed wounds was 20%. Some fac-
tors are considered as good prognosis for venous ulcer heal-
ing, such as wounds which are smaller than 20 cm2, time of 
occurrence less than 12 months and the presence of epi-
thelialization greater than 10% of the surface in the first 50 
days of treatment(19). In this group, the lesions were smaller 
than 4 cm2, favorable factor to healing. However, the lesion 
time of most of the ulcers was greater than 12 months, a 
complicating factor for the healing process. The prolonged 
time of active ulcer proved to be an independent factor as-
sociated with poor prognosis for healing, however, the size 
of the ulcer at baseline showed no significant statistical in-
terference in healing(3,14).
Regarding the type of tissue, all ulcers assessed by the 
study showed some degree of liquefaction necrosis or slough, 
which is a thin consistency devitalized tissue, mucoid, soft, 
yellowish gray color, formed by bacteria, fibrin, elastin, col-
lagen, leucocytes, cell exudate and fragments. The presence 
of slough is considered a bad condition for healing(16).
The results showed a significant decrease in slough tis-
sue, demonstrating that the papain gel was effective as a 
debriding. Although not observed by statistical tests in the 
granulation tissue variation, there was a significant increase 
in epithelialization of the bed of venous ulcers, indicating 
that the papain gel used favored the healing process. The 
presence of granulation tissue is a good prognosis of the 
wound, since the next stage, epithelialization should initiate 
its closure, which depends on the completion of this tissue 
lesion(14).
There was also an improvement in depth of venous ul-
cers, the type and amount of exudate and edema. The exu-
date in the wound bed is a physiological process in abun-
dance in the inflammatory phase of chronic ulcers. The 
serous exudate demonstrates the absence of infection in the 
wound bed, with a better prognosis(14).
However, excessive exudate may lead to irritative exu-
dation through dermatitis maceration of skin adjacent to 
the ulcer with increased local inflammation and microbial 
eczema caused by bacterial colonization, delaying healing. 
Large amounts of exudate is another bad condition for ulcer 
healing(16).
Wounds with less exudate and odor contribute to pa-
tient rehabilitation in social centers, improving the quality 
of life for these clients(15). The superficialization of ulcers, 
reducing the amount and type exudate are improvement 
factors which indicate the progress of the healing process.
Pain is a common symptom in patients with venous 
ulcers, which compromises the quality of life, due to the 
limitations of physical activities and provision for daily life 
activities, but adequate assistance can contribute to better 
understanding of pain and its reduction(15,20-22).
Edema interferes with oxygenation and nutrition of 
tissue in formation, preventing the synthesis of collagen, 
decreasing cell proliferation and reducing tissue resistance 
to infection. It is common in venous insufficiency, and its 
reduction can improve the healing process(16).
Nursing consultations using dressing with papain gel 
met the main guidelines for the treatment of venous ulcers, 
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as nurses were able to advise the patient and to prevent 
venous stasis, stimulating rest and elevation of the lower 
limbs, using a coverage which maintained an humid condi-
tions, leading to decreased pain and exudate(15). Continu-
ous monitoring of patients with ulcers helps to improve the 
activities of self-care(20).
None of the products used by patients in the adjacent 
skin caused any interaction with papain that could be con-
sidered harmful or that there was need for suspension and/
or notification. The advice provided to patients regarding 
the care of the skin adjacent to the venous ulcers, through 
the use of moisturizing and oil, associated with the use of 
papain gels in the wound bed showed improved adjacent 
skin hydration.
The characteristics of ulcer edges define the propensity 
of ulcer healing. In this study, the edges become epitheli-
alized and only one participant showed maceration. The 
epithelialized tissue edges tend to be thinner, demonstrat-
ing that the healing process is progressing. Inflammatory 
signs such as pain, redness and swelling at the edges and 
in the perilesional region can indicate infection. The mac-
eration can be caused by prolonged exposure of the skin 
to fluids(16).
CONCLUSION
In this study, 30 ulcers of 16 volunteers were assessed 
throughout 90 days of treatment. Most participants were 
female with an average age of 62.31 years (SD = ± 10.15), 
obese with Hypertension and Diabetes Mellitus.
Considering the whole sample, there was a significant 
reduction in lesion area by the size of 50%. In subgroups 
analysis, a significant average reduction of 60% in the sub-
group <3.9 cm2 and 66.6% in ulcers with area from 3.9 to 
20 cm2, ie papain gels were effective in reducing the wounds 
area of up to 20 cm2. However, there was also significant 
average reduction of 23.7% in wounds larger than 20 cm2.
The percentage of healed wounds was 20%, with an aver-
age healing time of 56.67 days, ± 9.83. There was significant 
reduction of slough and increased tissue epithelization, re-
ducing the wound depth, the amount of exudation and edema.
As limitations of the study, we mention the sample size 
due to the difficulty of recruiting patients who met the clin-
ical study inclusion criteria, including the follow-up time.
It is concluded that 2% and 4% papain gels were effective 
in healing of venous ulcers and can be safely used in slough 
and granulation tissue, without reports of adverse events.
RESUMO
Objetivo: Analisar a efetividade dos géis de papaína a 2% e 4% no reparo tecidual das úlceras venosas. Método: Estudo quase-
experimental, com amostra consecutiva de 16 pacientes com 30 úlceras venosas, atendidos no ambulatório de um hospital universitário, 
de abril a novembro de 2011, com formulário para avaliação clínica do paciente e da lesão. Variáveis analisadas pelos testes de Wilcoxon e 
McNemar (p < 0,05). Resultados: Predomínio do sexo feminino; idade entre 51 e 59 anos; obesas; com Hipertensão Arterial Sistêmica. 
Quanto às úlceras, houve redução média de 7,9 cm2 (50% do tamanho) em 90 dias; 20% cicatrizaram completamente em 56,67 dias. 
Houve aumento da epitelização, redução significativa do esfacelo e do edema, melhora na profundidade, no tipo e na quantidade de 
exsudato (p < 0,0001). Conclusão: Os géis de papaína a 2% e 4% foram efetivos na cicatrização de úlceras venosas.
DESCRITORES
Úlcera Varicosa; Úlcera da Perna; Papaína; Resultado do Tratamento; Enfermagem.
RESUMEn
Objetivo: Analizar la efectividad de los geles de papaína al 2% y al 4% en la reparación del tejido de las úlceras venosas. Método: 
Estudio cuasi-experimental, con muestra consecutiva de 16 pacientes con 30 úlceras venosas, atendidos en el ambulatorio de un hospital 
universitario, de abril a noviembre de 2011, con formulario para evaluación clínica del paciente y la lesión. Variables analizadas por 
las pruebas de Wilcoxon y McNemar (p < 0,05). Resultados: Predominio del sexo femenino; edad entre 51 y 59 años; obesas; con 
Hipertensión Arterial Sistémica. En cuanto a las úlceras, hubo reducción media de 7,9 cm2 (el 50% del tamaño) en 90 días; el 20% 
cicatrizaron completamente en 56,67 días. Hubo incremento de la epitelización, reducción significativa de la esfacelación y el edema, 
mejora en la profundidad, la clase y la cantidad de exudado (p < 0,0001). Conclusión: Los geles de papaína al 2% y al 4% fueron efectivos 
en la cicatrización de úlceras venosas.
DESCRIPTORES
Úlcera Varicosa; Úlcera de la Pierna; Papaína; Resultado del Tratamiento; Enfermería.
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